Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients,European Journal of Clinical Investigation

当前位置： X-MOL 学术 › Eur. J. Clin. Investig. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients
European Journal of Clinical Investigation ( IF 4.4 ) Pub Date : 2021-09-13 , DOI: 10.1111/eci.13679
Benjamin J R Buckley _{1,

2} , Stephanie L Harrison _{1,

2} , Elnara Fazio-Eynullayeva ₃ , Paula Underhill ₄ , Deirdre A Lane _{1,

2,

5} , Gregory Y H Lip _{1,

2,

5}

Affiliation

COVID-19 has a wide spectrum of cardiovascular sequelae including myocarditis and pericarditis; however, the prevalence and clinical impact are unclear. We investigated the prevalence of new-onset myocarditis/pericarditis and associated adverse cardiovascular events in patients with COVID-19.

中文翻译：